These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26511220)

  • 1. Ten-year longitudinal study of factors influencing nocturnal asthma symptoms among Asian patients in primary care.
    Tan NC; Nadkarni NV; Lye WK; Sankari U; Nguyen vH
    NPJ Prim Care Respir Med; 2015 Oct; 25():15064. PubMed ID: 26511220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2011 May; (5):CD003137. PubMed ID: 21563136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of asthma therapy by a novel formoterol multidose dry powder inhaler.
    Moeller M; Grimmbacher S; Munzel U
    Arzneimittelforschung; 2008; 58(4):168-73. PubMed ID: 18540478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of leukotriene receptor antagonists are associated with a similar risk of asthma exacerbations as inhaled corticosteroids.
    Wu AC; Li L; Fung V; Kharbanda EO; Larkin EK; Vollmer WM; Butler MG; Miroshnik I; Rusinak D; Davis RL; Hartert T; Weiss ST; Lieu TA
    J Allergy Clin Immunol Pract; 2014; 2(5):607-13. PubMed ID: 25213056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Acting β-Agonist in Combination or Separate Inhaler as Step-Up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids.
    Turner S; Richardson K; Murray C; Thomas M; Hillyer EV; Burden A; Price DB;
    J Allergy Clin Immunol Pract; 2017; 5(1):99-106.e3. PubMed ID: 27421902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.
    Vogelmeier C; Naya I; Ekelund J
    Clin Drug Investig; 2012 Jul; 32(7):439-49. PubMed ID: 22607479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescriptive adherence to GINA guidelines and asthma control: An Italian cross sectional study in general practice.
    Baldacci S; Simoni M; Maio S; Angino A; Martini F; Sarno G; Cerrai S; Silvi P; Pala AP; Bresciani M; Paggiaro P; Viegi G;
    Respir Med; 2019 Jan; 146():10-17. PubMed ID: 30665506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting beta-agonists and the risk of intensive care unit admission in children.
    Jacobs TS; Jones BL; MacGinnitie AJ
    J Asthma; 2012 Jun; 49(5):450-5. PubMed ID: 22540879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective Analysis of the Starting Dose of Combined ICS/LABA for Cough-variant Asthma and Cough-predominant Asthma.
    Nakajima T; Nagano T; Nishimura Y
    In Vivo; 2022; 36(2):949-953. PubMed ID: 35241554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
    Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting β2-agonist step-off in patients with controlled asthma.
    Brozek JL; Kraft M; Krishnan JA; Cloutier MM; Lazarus SC; Li JT; Santesso N; Strunk RC; Casale TB
    Arch Intern Med; 2012 Oct; 172(18):1365-75. PubMed ID: 22928176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM; Greenstone IR; Ducharme FM
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.
    Chung KF; Caramori G; Adcock IM
    Eur J Clin Pharmacol; 2009 Sep; 65(9):853-71. PubMed ID: 19557399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal follow-up period after switching to another inhaled corticosteroid/long-acting β2 agonist in patients with asthma: A retrospective study using Japanese administrative claims data.
    Kondo R; Maeda S; Kikuchi A; Kiyono H; Sato T
    PLoS One; 2022; 17(10):e0276001. PubMed ID: 36227895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial.
    Wechsler ME; Yawn BP; Fuhlbrigge AL; Pace WD; Pencina MJ; Doros G; Kazani S; Raby BA; Lanzillotti J; Madison S; Israel E;
    JAMA; 2015 Oct; 314(16):1720-30. PubMed ID: 26505596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of early effects of budesonide/formoterol maintenance and reliever therapy with fluticasone furoate/vilanterol for asthma patients requiring step-up from inhaled corticosteroid monotherapy.
    Hozawa S; Terada M; Haruta Y; Hozawa M
    Pulm Pharmacol Ther; 2016 Apr; 37():15-23. PubMed ID: 26850307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Step-down treatment from medium-dosage of budesonide/formoterol in controlled asthma.
    Mori K; Fujisawa T; Inui N; Hashimoto D; Enomoto N; Nakamura Y; Kuroishi S; Yokomura K; Toyoshima M; Imokawa S; Yamada T; Shirai T; Masuda M; Hayakawa H; Chida K; Suda T
    Respir Med; 2016 Oct; 119():1-6. PubMed ID: 27692128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.